Brad serves as an advisor to the firm’s management and investment committee in developing strategy and evaluation of investment opportunities. As a Senior Advisor, he has a particular focus on evaluating new investment opportunities in the healthcare and technology industries.
Dr. Hirsch is CEO and Co-Founder of SignalPath, a start up leveraging technology to make clinical trials more efficient and effective for research sites and sponsors. He is also a practicing medical oncologist with Texas Oncology and a principal investigator. Prior to his present focus, he held leadership roles in technology companies and academics including as Senior Medical Director for Flatiron Health and as a faculty member of the Duke University School of Medicine and the Duke Clinical Research Institute. Across all of his roles, he focuses on the use of novel technology platforms to advance the frontier in medicine.
Board Memberships (Current and Past)
Parkland Hospital Foundation, current
National Outdoor Leadership School (NOLS) Advisory Council, current
St. Mark’s School of Texas, current
Boys and Girls Club of Dallas, past
M.B.A., with concentration in Health Sector Management, Fuqua School at Duke University
M.D., UT Southwestern Medical School
B.A. in Economics and the Biological Basis of Behavior, University of Pennsylvania